1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Psoriasis Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Tumor Necrosis Factor Inhibitor 1.2.3 Interleukin Inhibitors 1.2.4 Others 1.3 Market by Application 1.3.1 Global Psoriasis Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Topicals 1.3.3 Systemic 1.3.4 Biologics 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Psoriasis Drugs Market Perspective (2017-2028) 2.2 Psoriasis Drugs Growth Trends by Region 2.2.1 Psoriasis Drugs Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Psoriasis Drugs Historic Market Size by Region (2017-2022) 2.2.3 Psoriasis Drugs Forecasted Market Size by Region (2023-2028) 2.3 Psoriasis Drugs Market Dynamics 2.3.1 Psoriasis Drugs Industry Trends 2.3.2 Psoriasis Drugs Market Drivers 2.3.3 Psoriasis Drugs Market Challenges 2.3.4 Psoriasis Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Psoriasis Drugs Players by Revenue 3.1.1 Global Top Psoriasis Drugs Players by Revenue (2017-2022) 3.1.2 Global Psoriasis Drugs Revenue Market Share by Players (2017-2022) 3.2 Global Psoriasis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Psoriasis Drugs Revenue 3.4 Global Psoriasis Drugs Market Concentration Ratio 3.4.1 Global Psoriasis Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Psoriasis Drugs Revenue in 2021 3.5 Psoriasis Drugs Key Players Head office and Area Served 3.6 Key Players Psoriasis Drugs Product Solution and Service 3.7 Date of Enter into Psoriasis Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Psoriasis Drugs Breakdown Data by Type 4.1 Global Psoriasis Drugs Historic Market Size by Type (2017-2022) 4.2 Global Psoriasis Drugs Forecasted Market Size by Type (2023-2028) 5 Psoriasis Drugs Breakdown Data by Application 5.1 Global Psoriasis Drugs Historic Market Size by Application (2017-2022) 5.2 Global Psoriasis Drugs Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Psoriasis Drugs Market Size (2017-2028) 6.2 North America Psoriasis Drugs Market Size by Type 6.2.1 North America Psoriasis Drugs Market Size by Type (2017-2022) 6.2.2 North America Psoriasis Drugs Market Size by Type (2023-2028) 6.2.3 North America Psoriasis Drugs Market Share by Type (2017-2028) 6.3 North America Psoriasis Drugs Market Size by Application 6.3.1 North America Psoriasis Drugs Market Size by Application (2017-2022) 6.3.2 North America Psoriasis Drugs Market Size by Application (2023-2028) 6.3.3 North America Psoriasis Drugs Market Share by Application (2017-2028) 6.4 North America Psoriasis Drugs Market Size by Country 6.4.1 North America Psoriasis Drugs Market Size by Country (2017-2022) 6.4.2 North America Psoriasis Drugs Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Psoriasis Drugs Market Size (2017-2028) 7.2 Europe Psoriasis Drugs Market Size by Type 7.2.1 Europe Psoriasis Drugs Market Size by Type (2017-2022) 7.2.2 Europe Psoriasis Drugs Market Size by Type (2023-2028) 7.2.3 Europe Psoriasis Drugs Market Share by Type (2017-2028) 7.3 Europe Psoriasis Drugs Market Size by Application 7.3.1 Europe Psoriasis Drugs Market Size by Application (2017-2022) 7.3.2 Europe Psoriasis Drugs Market Size by Application (2023-2028) 7.3.3 Europe Psoriasis Drugs Market Share by Application (2017-2028) 7.4 Europe Psoriasis Drugs Market Size by Country 7.4.1 Europe Psoriasis Drugs Market Size by Country (2017-2022) 7.4.2 Europe Psoriasis Drugs Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Psoriasis Drugs Market Size (2017-2028) 8.2 Asia-Pacific Psoriasis Drugs Market Size by Type 8.2.1 Asia-Pacific Psoriasis Drugs Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Psoriasis Drugs Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Psoriasis Drugs Market Share by Type (2017-2028) 8.3 Asia-Pacific Psoriasis Drugs Market Size by Application 8.3.1 Asia-Pacific Psoriasis Drugs Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Psoriasis Drugs Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Psoriasis Drugs Market Share by Application (2017-2028) 8.4 Asia-Pacific Psoriasis Drugs Market Size by Region 8.4.1 Asia-Pacific Psoriasis Drugs Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Psoriasis Drugs Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Psoriasis Drugs Market Size (2017-2028) 9.2 Latin America Psoriasis Drugs Market Size by Type 9.2.1 Latin America Psoriasis Drugs Market Size by Type (2017-2022) 9.2.2 Latin America Psoriasis Drugs Market Size by Type (2023-2028) 9.2.3 Latin America Psoriasis Drugs Market Share by Type (2017-2028) 9.3 Latin America Psoriasis Drugs Market Size by Application 9.3.1 Latin America Psoriasis Drugs Market Size by Application (2017-2022) 9.3.2 Latin America Psoriasis Drugs Market Size by Application (2023-2028) 9.3.3 Latin America Psoriasis Drugs Market Share by Application (2017-2028) 9.4 Latin America Psoriasis Drugs Market Size by Country 9.4.1 Latin America Psoriasis Drugs Market Size by Country (2017-2022) 9.4.2 Latin America Psoriasis Drugs Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Psoriasis Drugs Market Size (2017-2028) 10.2 Middle East & Africa Psoriasis Drugs Market Size by Type 10.2.1 Middle East & Africa Psoriasis Drugs Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Psoriasis Drugs Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Psoriasis Drugs Market Share by Type (2017-2028) 10.3 Middle East & Africa Psoriasis Drugs Market Size by Application 10.3.1 Middle East & Africa Psoriasis Drugs Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Psoriasis Drugs Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Psoriasis Drugs Market Share by Application (2017-2028) 10.4 Middle East & Africa Psoriasis Drugs Market Size by Country 10.4.1 Middle East & Africa Psoriasis Drugs Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Psoriasis Drugs Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AbbVie 11.1.1 AbbVie Company Details 11.1.2 AbbVie Business Overview 11.1.3 AbbVie Psoriasis Drugs Introduction 11.1.4 AbbVie Revenue in Psoriasis Drugs Business (2017-2022) 11.1.5 AbbVie Recent Developments 11.2 Amgen 11.2.1 Amgen Company Details 11.2.2 Amgen Business Overview 11.2.3 Amgen Psoriasis Drugs Introduction 11.2.4 Amgen Revenue in Psoriasis Drugs Business (2017-2022) 11.2.5 Amgen Recent Developments 11.3 Johnson & Johnson 11.3.1 Johnson & Johnson Company Details 11.3.2 Johnson & Johnson Business Overview 11.3.3 Johnson & Johnson Psoriasis Drugs Introduction 11.3.4 Johnson & Johnson Revenue in Psoriasis Drugs Business (2017-2022) 11.3.5 Johnson & Johnson Recent Developments 11.4 Novartis 11.4.1 Novartis Company Details 11.4.2 Novartis Business Overview 11.4.3 Novartis Psoriasis Drugs Introduction 11.4.4 Novartis Revenue in Psoriasis Drugs Business (2017-2022) 11.4.5 Novartis Recent Developments 11.5 Eli Lilly & Company 11.5.1 Eli Lilly & Company Company Details 11.5.2 Eli Lilly & Company Business Overview 11.5.3 Eli Lilly & Company Psoriasis Drugs Introduction 11.5.4 Eli Lilly & Company Revenue in Psoriasis Drugs Business (2017-2022) 11.5.5 Eli Lilly & Company Recent Developments 11.6 AstraZeneca 11.6.1 AstraZeneca Company Details 11.6.2 AstraZeneca Business Overview 11.6.3 AstraZeneca Psoriasis Drugs Introduction 11.6.4 AstraZeneca Revenue in Psoriasis Drugs Business (2017-2022) 11.6.5 AstraZeneca Recent Developments 11.7 Celgene Corporation 11.7.1 Celgene Corporation Company Details 11.7.2 Celgene Corporation Business Overview 11.7.3 Celgene Corporation Psoriasis Drugs Introduction 11.7.4 Celgene Corporation Revenue in Psoriasis Drugs Business (2017-2022) 11.7.5 Celgene Corporation Recent Developments 11.8 UCB 11.8.1 UCB Company Details 11.8.2 UCB Business Overview 11.8.3 UCB Psoriasis Drugs Introduction 11.8.4 UCB Revenue in Psoriasis Drugs Business (2017-2022) 11.8.5 UCB Recent Developments 11.9 Merck 11.9.1 Merck Company Details 11.9.2 Merck Business Overview 11.9.3 Merck Psoriasis Drugs Introduction 11.9.4 Merck Revenue in Psoriasis Drugs Business (2017-2022) 11.9.5 Merck Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Psoriasis Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Tumor Necrosis Factor Inhibitor Table 3. Key Players of Interleukin Inhibitors Table 4. Key Players of Others Table 5. Global Psoriasis Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 6. Global Psoriasis Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Psoriasis Drugs Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Psoriasis Drugs Market Share by Region (2017-2022) Table 9. Global Psoriasis Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Psoriasis Drugs Market Share by Region (2023-2028) Table 11. Psoriasis Drugs Market Trends Table 12. Psoriasis Drugs Market Drivers Table 13. Psoriasis Drugs Market Challenges Table 14. Psoriasis Drugs Market Restraints Table 15. Global Psoriasis Drugs Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Psoriasis Drugs Revenue Share by Players (2017-2022) Table 17. Global Top Psoriasis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Drugs as of 2021) Table 18. Ranking of Global Top Psoriasis Drugs Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Psoriasis Drugs Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Psoriasis Drugs Product Solution and Service Table 22. Date of Enter into Psoriasis Drugs Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Psoriasis Drugs Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Psoriasis Drugs Revenue Market Share by Type (2017-2022) Table 26. Global Psoriasis Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Psoriasis Drugs Revenue Market Share by Type (2023-2028) Table 28. Global Psoriasis Drugs Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Psoriasis Drugs Revenue Share by Application (2017-2022) Table 30. Global Psoriasis Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Psoriasis Drugs Revenue Share by Application (2023-2028) Table 32. North America Psoriasis Drugs Market Size by Type (2017-2022) & (US$ Million) Table 33. North America Psoriasis Drugs Market Size by Type (2023-2028) & (US$ Million) Table 34. North America Psoriasis Drugs Market Size by Application (2017-2022) & (US$ Million) Table 35. North America Psoriasis Drugs Market Size by Application (2023-2028) & (US$ Million) Table 36. North America Psoriasis Drugs Market Size by Country (2017-2022) & (US$ Million) Table 37. North America Psoriasis Drugs Market Size by Country (2023-2028) & (US$ Million) Table 38. Europe Psoriasis Drugs Market Size by Type (2017-2022) & (US$ Million) Table 39. Europe Psoriasis Drugs Market Size by Type (2023-2028) & (US$ Million) Table 40. Europe Psoriasis Drugs Market Size by Application (2017-2022) & (US$ Million) Table 41. Europe Psoriasis Drugs Market Size by Application (2023-2028) & (US$ Million) Table 42. Europe Psoriasis Drugs Market Size by Country (2017-2022) & (US$ Million) Table 43. Europe Psoriasis Drugs Market Size by Country (2023-2028) & (US$ Million) Table 44. Asia Pacific Psoriasis Drugs Market Size by Type (2017-2022) & (US$ Million) Table 45. Asia Pacific Psoriasis Drugs Market Size by Type (2023-2028) & (US$ Million) Table 46. Asia Pacific Psoriasis Drugs Market Size by Application (2017-2022) & (US$ Million) Table 47. Asia Pacific Psoriasis Drugs Market Size by Application (2023-2028) & (US$ Million) Table 48. Asia Pacific Psoriasis Drugs Market Size by Region (2017-2022) & (US$ Million) Table 49. Asia Pacific Psoriasis Drugs Market Size by Region (2023-2028) & (US$ Million) Table 50. Latin America Psoriasis Drugs Market Size by Type (2017-2022) & (US$ Million) Table 51. Latin America Psoriasis Drugs Market Size by Type (2023-2028) & (US$ Million) Table 52. Latin America Psoriasis Drugs Market Size by Application (2017-2022) & (US$ Million) Table 53. Latin America Psoriasis Drugs Market Size by Application (2023-2028) & (US$ Million) Table 54. Latin America Psoriasis Drugs Market Size by Country (2017-2022) & (US$ Million) Table 55. Latin America Psoriasis Drugs Market Size by Country (2023-2028) & (US$ Million) Table 56. Middle East and Africa Psoriasis Drugs Market Size by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa Psoriasis Drugs Market Size by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa Psoriasis Drugs Market Size by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa Psoriasis Drugs Market Size by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa Psoriasis Drugs Market Size by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa Psoriasis Drugs Market Size by Country (2023-2028) & (US$ Million) Table 62. AbbVie Company Details Table 63. AbbVie Business Overview Table 64. AbbVie Psoriasis Drugs Product Table 65. AbbVie Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million) Table 66. AbbVie Recent Developments Table 67. Amgen Company Details Table 68. Amgen Business Overview Table 69. Amgen Psoriasis Drugs Product Table 70. Amgen Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million) Table 71. Amgen Recent Developments Table 72. Johnson & Johnson Company Details Table 73. Johnson & Johnson Business Overview Table 74. Johnson & Johnson Psoriasis Drugs Product Table 75. Johnson & Johnson Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million) Table 76. Johnson & Johnson Recent Developments Table 77. Novartis Company Details Table 78. Novartis Business Overview Table 79. Novartis Psoriasis Drugs Product Table 80. Novartis Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million) Table 81. Novartis Recent Developments Table 82. Eli Lilly & Company Company Details Table 83. Eli Lilly & Company Business Overview Table 84. Eli Lilly & Company Psoriasis Drugs Product Table 85. Eli Lilly & Company Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million) Table 86. Eli Lilly & Company Recent Developments Table 87. AstraZeneca Company Details Table 88. AstraZeneca Business Overview Table 89. AstraZeneca Psoriasis Drugs Product Table 90. AstraZeneca Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million) Table 91. AstraZeneca Recent Developments Table 92. Celgene Corporation Company Details Table 93. Celgene Corporation Business Overview Table 94. Celgene Corporation Psoriasis Drugs Product Table 95. Celgene Corporation Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million) Table 96. Celgene Corporation Recent Developments Table 97. UCB Company Details Table 98. UCB Business Overview Table 99. UCB Psoriasis Drugs Product Table 100. UCB Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million) Table 101. UCB Recent Developments Table 102. Merck Company Details Table 103. Merck Business Overview Table 104. Merck Psoriasis Drugs Product Table 105. Merck Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million) Table 106. Merck Recent Developments Table 107. Research Programs/Design for This Report Table 108. Key Data Information from Secondary Sources Table 109. Key Data Information from Primary Sources List of Figures Figure 1. Global Psoriasis Drugs Market Share by Type: 2021 VS 2028 Figure 2. Tumor Necrosis Factor Inhibitor Features Figure 3. Interleukin Inhibitors Features Figure 4. Others Features Figure 5. Global Psoriasis Drugs Market Share by Application: 2021 VS 2028 Figure 6. Topicals Case Studies Figure 7. Systemic Case Studies Figure 8. Biologics Case Studies Figure 9. Psoriasis Drugs Report Years Considered Figure 10. Global Psoriasis Drugs Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Psoriasis Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Psoriasis Drugs Market Share by Region: 2021 VS 2028 Figure 13. Global Psoriasis Drugs Market Share by Players in 2021 Figure 14. Global Top Psoriasis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Drugs as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Psoriasis Drugs Revenue in 2021 Figure 16. North America Psoriasis Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 17. North America Psoriasis Drugs Market Size Market Share by Type (2017-2028) Figure 18. North America Psoriasis Drugs Market Size Market Share by Application (2017-2028) Figure 19. North America Psoriasis Drugs Market Size Share by Country (2017-2028) Figure 20. United States Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Psoriasis Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 23. Europe Psoriasis Drugs Market Size Market Share by Type (2017-2028) Figure 24. Europe Psoriasis Drugs Market Size Market Share by Application (2017-2028) Figure 25. Europe Psoriasis Drugs Market Size Share by Country (2017-2028) Figure 26. Germany Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. France Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. U.K. Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Italy Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Russia Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Nordic Countries Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Asia-Pacific Psoriasis Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 33. Asia Pacific Psoriasis Drugs Market Size Market Share by Type (2017-2028) Figure 34. Asia Pacific Psoriasis Drugs Market Size Market Share by Application (2017-2028) Figure 35. Asia Pacific Psoriasis Drugs Market Size Share by Region (2017-2028) Figure 36. China Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Japan Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. South Korea Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Southeast Asia Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. India Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Australia Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 42. Latin America Psoriasis Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 43. Latin America Psoriasis Drugs Market Size Market Share by Type (2017-2028) Figure 44. Latin America Psoriasis Drugs Market Size Market Share by Application (2017-2028) Figure 45. Latin America Psoriasis Drugs Market Size Share by Country (2017-2028) Figure 46. Mexico Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Brazil Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Middle East & Africa Psoriasis Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 49. Middle East and Africa Psoriasis Drugs Market Size Market Share by Type (2017-2028) Figure 50. Middle East and Africa Psoriasis Drugs Market Size Market Share by Application (2017-2028) Figure 51. Middle East and Africa Psoriasis Drugs Market Size Share by Country (2017-2028) Figure 52. Turkey Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Saudi Arabia Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. UAE Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. AbbVie Revenue Growth Rate in Psoriasis Drugs Business (2017-2022) Figure 56. Amgen Revenue Growth Rate in Psoriasis Drugs Business (2017-2022) Figure 57. Johnson & Johnson Revenue Growth Rate in Psoriasis Drugs Business (2017-2022) Figure 58. Novartis Revenue Growth Rate in Psoriasis Drugs Business (2017-2022) Figure 59. Eli Lilly & Company Revenue Growth Rate in Psoriasis Drugs Business (2017-2022) Figure 60. AstraZeneca Revenue Growth Rate in Psoriasis Drugs Business (2017-2022) Figure 61. Celgene Corporation Revenue Growth Rate in Psoriasis Drugs Business (2017-2022) Figure 62. UCB Revenue Growth Rate in Psoriasis Drugs Business (2017-2022) Figure 63. Merck Revenue Growth Rate in Psoriasis Drugs Business (2017-2022) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

AbbVie Amgen Johnson & Johnson Novartis Eli Lilly & Company AstraZeneca Celgene Corporation UCB Merck